My XDC COIN BullRun Price Prediction for 2026/2027
1 extracted signal · 0 resolved · 1 still active
Altcoin DoctorIndependent analyst profile- Source published
- 28 Sept 2026, 10:27 UTC
- Recorded by Tahlil Plus
- 28 Sept 2026, 11:15 UTC

AI-generated source summary
The video analyzes XDCUSDT on a weekly timeframe. The current price is approximately $0.03417. The analysis utilizes Fibonacci retracement levels drawn from the peak of the bull market to the bottom of the bear market. Several potential target zones are identified: 0.02164 (0.00236 Fibonacci level), 0.01870, 0.00863, and the ultimate lowest target at 0.00565. The analysis suggests a bearish trend, with the price expected to fall further. A fail bound price, invalidating this bearish outlook, is set slightly above the current price at approximately $0.05583, which corresponds to the 0.15 Fibonacci level. The presenter also touches upon broader market trends by referencing USDT dominance and total crypto market cap charts, indicating that a rising USDT dominance often correlates with a declining cryptocurrency market, and vice-versa. The overall sentiment for XDCUSDT is bearish in the short to medium term, with potential for a significant drop if key support levels are broken.
AI-generated summary based on the source content.
Signal outcomes at a glance
Tracking LiveSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Source processing completed
Source analysis and structured extraction completed.
- Live evaluation in progress
1 signal remains active.
Altcoin Doctor
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
